Filing Details
- Accession Number:
- 0001209191-21-060367
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-13 16:37:55
- Reporting Period:
- 2021-10-12
- Accepted Time:
- 2021-10-13 16:37:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1300699 | Athenex Inc. | ATNX | Pharmaceutical Preparations (2834) | 431985966 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1314254 | Jinn Wu | C/O Athenex, Inc. 1001 Main Street, Suite 600 Buffalo NY 14203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-10-01 | 10,000 | $2.67 | 413,208 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $4.55 | 2013-01-02 | 2023-01-02 | 40,000 | 40,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $4.55 | 2014-02-12 | 2024-02-12 | 10,000 | 10,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $5.50 | 2015-02-05 | 2025-02-05 | 54,000 | 54,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $5.50 | 2017-03-20 | 2025-03-20 | 96,000 | 96,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $11.00 | 2021-06-13 | 2027-06-13 | 28,500 | 28,500 | Direct |
| Common Stock | Stock Option (Right to Buy) | $17.30 | 2028-03-27 | 16,500 | 16,500 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $13.17 | 2029-02-28 | 15,000 | 15,000 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $12.45 | 2030-06-05 | 12,500 | 12,500 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $3.80 | 2031-08-03 | 7,500 | 7,500 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 7,500 | 7,500 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-01-02 | 40,000 | 40,000 | Direct |
| 2024-02-12 | 10,000 | 10,000 | Direct |
| 2025-02-05 | 54,000 | 54,000 | Direct |
| 2025-03-20 | 96,000 | 96,000 | Direct |
| 2027-06-13 | 28,500 | 28,500 | Direct |
| 2028-03-27 | 16,500 | 16,500 | Direct |
| 2029-02-28 | 15,000 | 15,000 | Direct |
| 2030-06-05 | 12,500 | 12,500 | Direct |
| 2031-08-03 | 7,500 | 7,500 | Direct |
| 7,500 | 7,500 | Direct |
Footnotes
- This option vests in four equal annual installments beginning on March 27, 2019.
- This option vests in four equal annual installments beginning on February 28, 2020.
- This option vests in four equal annual installments beginning on June 5, 2021.
- This option vests on August 3, 2022.
- Each restricted stock unit represents a contingent right to receive one share of stock.
- The restricted stock units vest on August 3, 2022.
Billionaire Hedge Funds
